BLOCKADE OF EPIDERMAL GROWTH FACTOR RECEPTOR, CYCLOXYGENASE-2 (COX-2) AND MAMMALIAN TARGET OF RAPAMYCIN (M-TOR) IN ANIMAL MODEL OF LUNG CANCER

Abstract

To explore the effectiveness and possible toxicity of the use of epidermal growth factor receptor inhibitor (EGFR Inhibitor), Celecoxib (COX2 inhibitor) and Sirolimus (m-TOR inhibitor) as single agents and drug combinations for the treatment of lung cancer in an experimental model. Lung cancer was induced in Balb-C mice by intraperitoneal injection urethane. Mice were treated with water (control) , Erlotinib (E) (50 mg/kg), Celecoxib (X) (50 mg/kg), Sirolimus (R) (2 mg/kg) given alone and in the following doublet and triplet combinations in the same dosages for 7 days. The number of pulmonary nodules in the combined treatment was significantly inhibited compared with control (p=0.010); E (p=0.028), EX (p=0.010), ERX (p=0.040) showed a smaller number of statistically significant nodules. Regarding coat changes we observe statistically significant differences among groups (p<0.001) where ERX and ER had a higher occurrence of this change. There was a higher incidence of skin rashes in groups: E (p<0.001), ER (p<0.0001), and ERX (p<0.001). Regarding weight we identify weight loss in the ERX (p=0.025). The combination of EGFR inhibitor, COX-2 inhibitor and m-TOR inhibitor had anti-tumor activity in experimental lung cancer. The combination of Celecoxib treatment with Erlotinib is a suggestion for decrease of dermatological events in patients. The combination of EGFR inhibitor and Sirolimus does not decrease the number of lung nodules and potentiates adverse events.

Authors and Affiliations

T V Faria, T M V Faria, J Barbosa, S N. Lucio, F Ometto, J P S N Lima, S V Serrano, P M Cury

Keywords

Related Articles

DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING ORAL FILM CONTAINING ARIPIPRAZOLE

The present investigation was aimed with the objective of developing fast dissolving oral films of Aripiprazole to attain quick onset of action for the better management of Schizophrenia. Fourteen formulations (F1-F14) o...

OPTIMIZATION AND PRODUCTION OF NEOMYCIN FROM DIFFERENT AGRO INDUSTRIAL WASTES IN SOLID STATE FERMENTATION

The cost of neomycin production may be significantly decreased by using inexpensive carbon substrates like agricultural residues. However, scarce information can be found in the literature about the utilization of cellul...

PROGRESS AND PROSPECTS IN THERAPEUTICS AGAINST HIV INFECTION

Tremendous advances have occurred in recent decades in the development of safe and effective medications for the treatment of viral diseases. Currently there are more than 20 HIV drugs approved for use in humans. Combine...

COMPARISON OF DIFFERENT GRANULATION TECHNIQUES FOR LACTOSE MONOHYDRATE

The objective of this study was directed to improve the physical and technical properties of poorly flowing and highly cohesive Lactose monohydrate to solve the most important problem that affects tablet manufacture. To...

SYNTHESIS AND SCREENING OF QUINAZOLINE ANALOGUES AS CYTOTOXIC AGENTS

Synthesis of novel quinazoline derivatives was performed from reaction of N-benzoyl substituted piperazine-1-carbothioamide with 4-(2-chlormethyl) quinazoline-4-yloxy phenyl benzamide derivatives and screened for their i...

Download PDF file
  • EP ID EP625207
  • DOI 10.25004/IJPSDR.2016.080601
  • Views 79
  • Downloads 0

How To Cite

T V Faria, T M V Faria, J Barbosa, S N. Lucio, F Ometto, J P S N Lima, S V Serrano, P M Cury (2016). BLOCKADE OF EPIDERMAL GROWTH FACTOR RECEPTOR, CYCLOXYGENASE-2 (COX-2) AND MAMMALIAN TARGET OF RAPAMYCIN (M-TOR) IN ANIMAL MODEL OF LUNG CANCER. International Journal of Pharmaceutical Sciences and Drug Research, 8(6), 281-286. https://europub.co.uk/articles/-A-625207